MabVax Therapeutics (Nasdaq: MBVX) announced it has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center (MSK) for the development of novel Chimeric Antigen Receptor (CAR).

I am producing independent equity research on small-cap biotech and pharma names. The monthly price is only $50. Please check it out! Jason